GAIL INDIA Q4 - TOTAL COST AT Rs. 10860 CR VS Rs. 13880 CR YoY |  GAIL INDIA Q4 - NET SALES AT Rs. 11630 CR; ESTIMATE OF Rs. 13400 CR
  NIFTY  7,973.10  0.48%
  SENSEX  26,035.60  0.60%
 CURRENCY  Rs  67.34/$ 75.23/€, 99.06/£
  GOLD  29,086.00  0.45%
  SILVER  39,558.00  0.84%
  DAX  10,205.20  1.47%
  FTSE  6,262.85  0.70%
  CAC  4,481.64  1.03%
  HANG SENG  20,368.10  2.71%
  NIKKEI  16,757.30  1.57%
  Shanghai Composite  2,815.09  -0.14%
  DOW JONES  17,851.50  0.82%
  NASDAQ  4,894.89  0.70%
  S&P 500  2,090.54  0.70%

Cipla & Roche Enter Mediation Talks

Video:

Play this video

June 13: Pharmaceutical giants Cipla and Roche have agreed to a mediation process to resolve their dispute over the patent of cancer drug Tarceva. A division bench of the Delhi High Court had suggested mediation to resolve the matter last month. Sohini Bhowmik takes you through the highlights.